CLINICAL TRIAL SUMMARY

MDACC Study No:RTOG 0232 (clinicaltrials.gov NCT No: NCT00063882)
Title:A Phase III Study Comparing Combined External Beam Radiation Transperineal Interstitial Permanent Brachytherapy with Brachytherapy Alone for Selected Patients with Intermediate Risk Prostatic Carcinoma
Principal Investigator:Steven J. Frank
Treatment Agent:Radiation
Study Status:Closed
Study Description:The goal of this clinical research study is to compare the effects of external
radiation treatments given before an internal radiation treatment, compared to
an internal radiation treatment alone. The internal radiation treatment is
brachytherapy (also known as implant therapy). The external radiation
treatment is external beam radiation. This will be tested in patients with
prostate cancer.

The safety and level of effectiveness of these treatments will be compared, as
well as participants' quality of life after treatment.

Hide details for General InformationGeneral Information

Disease Group:Prostate
Phase of Study:Phase III
Treatment Agents:Radiation
Treatment Location:Both at MDACC & outside MDACC at one or more Collaborating Sites or Institutions
Estimated Length of Stay in Houston:N/A
Supported By:Radiation Therapy Oncology Group (RTOG)
RTOG
Return Visit:Initial follow-up visit within 3-5 wks of implant to coincide with post-implant
CT.
Home Care:None


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Steven J. Frank
Dept:Radiation Oncology
For Clinical Trial Enrollment:713-563-5905
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults